Growth and development of a new subspecialty: Pediatric hepatology

Abstract

Several major forces converged to catalyze the formal emergence of a body of knowledge and an organized focus on disorders of the liver in early life. Attendant to the development of a focused clinical subspecialty the pace of patient-and laboratory-based research in the field quickened in parallel to decipher the consequences of genetic or metabolic aberrations on immature liver structure and function. The key research observations that catalyzed the emergence and subsequent rapid growth of Pediatric Hepatology include: (1) an understanding of the dynamic events occurring during hepatobiliary development and the importance of these physiologic variables that occur during liver maturation; (2) the recognition of the unique nature of inherited and acquired liver diseases that affect infants and children-such as biliary atresia and Reye's syndrome; and (3) redefinition of the once obscure inherited intrahepatic cholestatic diseases of the liver, which, in turn, provided insight into normal and abnormal hepatobiliary physiology. The clinical advances were highlighted by the development of specific approaches to the diagnosis and management of liver disease in infants and children, including both liver transplantation and nontransplant treatment options. These seminal events led to the expansion of the workforce, creating a critical mass consisting of individuals with focused, specialized skills and techniques. In-depth expertise allowed more accurate diagnosis and highly effective treatment strategies for advanced hepatobiliary disease in children. The demand for pediatric clinicians with experience in advanced hepatology allowed sub-sub-specialization to flourish. Continued maturation of the field led to definition of hepatology-focused curricular elements and educational content for Pediatric Gastroenterology training programs, and subsequently the development of program requirements for those who wished to acquire additional training in Pediatric Hepatology. A significant rite of passage was marked by the election of pediatric hepatologists to leadership positions in the American Association for the Study of Liver Diseases (AASLD). Further validation of the field occurred with approval of the petition for establishing a Certificate of Added Qualification in Transplant Hepatology by the American Board of Pediatrics. Here I relate my perspective on the history of the advances in our field and the contributions of many of the clinicians and scientists whose efforts led to the development of focused clinical, research, and training programs that improved the care of children with diseases of the liver. (HEPATOLOGY 2013;58:458-476) The ChallengeSince there was not a single linear pathway it appeared at first to be a daunting task to reconstruct the history and sequence of events leading to the emergence and maturation of a field of subspecialization. Therefore, it was a bit overwhelming to be asked by the editors of HEPATOLOGY to "look back on my career" and not only "tell us about your life story" but also "illus...

Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3

“…Although solid organ transplantation, including liver transplantation, is regarded as one of the most significant advances in medical science, it still faces various challenges such as organ unavailability, postoperative complications, and high costs3334. In the case of pediatric liver transplantation, there are additional problems such as growth retardation due to prolonged steroid exposure, lower physical and psychosocial function after liver transplantation, graft loss, and preoperative malnutrition3536. The identification of successful mechanism-based drugs for the treatment of PFIC3 is necessary to improve the quality of life in pediatric PFIC3 patients.…”

Patterns of Change in ACGME-Accredited Residency Programs and Positions: Implication for the Adequacy of GME Positions and Supply of Physicians in the United States

“…29 A limitation of our findings is that the data in the Databook are confined to accredited residencies and specialties, and the proportion of residents entering non-ACGME-accredited fellowship programs is not accounted for. Sources indicate this number is increasing, [30][31][32] and inclusion of these data would show even greater subspecialization rates for graduates of pipeline specialty programs.…”

The coming of age of a young subspecialty: paediatric hepatology

“…Ever since then, intrahepatic cholestasis has been at the centre of paediatric hepatology, although the focus has been moved to a certain extent from the study of peripheral metabolites to studies of the affects of proteins on the canalicular membrane, the hepatocytic nuclear membrane and lately the intestinal mucosa. Some years ago, at a monothematic meeting held by the American Association for the Study of Liver Diseases, a simplified list of the subtypes of chronic intrahepatic cholestasis was proposed (Table ) . With the help of next‐generation sequencing, and improved biochemical analytical methods such as high‐performance liquid chromatography‐mass spectrometry, the relative number of undiagnosed causes is shrinking, providing hope for innovative causal treatment .…”